Aridhia Secures Place On G-Cloud 6 Framework
News Feb 02, 2015
World-leading health informatics company Aridhia has successfully been awarded a place on the UK Government’s G-Cloud procurement portal for a second term, making its analytics platform, data science services, and app development capability widely accessible to healthcare providers and research collaborations.
The G-Cloud framework enables healthcare organisations such as NHS Trusts and Clinical Commissioning Groups (CCGs) to procure cloud-based Software as a Service (SaaS) systems and applications on a monthly subscription basis. This enables users to access Aridhia’s platform – AnalytiXagility – without the need for costly infrastructure investment and lengthy installation time.
Aridhia is the Edinburgh-based health informatics company that works collaboratively with health organisations, governments and research groups to further integrate healthcare, precision medicine and collaborative biomedical research. AnalytiXagility is Aridhia’s collaborative data science platform that has been deployed in the Stratified Medicine Scotland Innovation Centre (SMS-IC) and was recently used to underpin the successful Phase 1 bid for a Genomics England competition.
Four key services from AnalytiXagility are being made available to healthcare providers through the procurement portal. The De-identification Service anonymises healthcare datasets, thereby making it possible to safely link data for research purposes while mitigating the risk of identifying individuals. By accessing the platform’s Data Safe Haven and collaborative workspaces, users can bring together multiple data types in an environment supporting strict information governance protocols.
The Diabetes Dataprofiler informs understanding of the diabetes patient population and its clinical outcomes, aligned to best practice guidelines and clinical targets. Aridhia’s Data Lab Services can be used to extend organisations’ data science and app development capability, to develop analytics solutions or kick-start an informatics project by engaging with the team’s expertise in information governance, data strategy, and the capture, management, linkage and analysis of vast data sets.
The availability of these services reflects a key recommendation in the report published in November last year by the Department of Health and the National Information Board – Personalised Health and Care 2020 – by taking advantage of cloud-based technology that offers flexible procurement routes, making use of open technologies at the forefront of innovation in delivering health-as-a-platform, and ultimately delivering better value and better patient outcomes.
David Sibbald, CEO of Aridhia, said: “Developing the technology to bring together individual data sets and draw meaningful clinical features from analysis of the data is only half the battle; ensuring the technology is available to the healthcare providers that need it, readily available in a way that they can procure it, is the other half. By making these key services available to NHS trusts, CCGs and health boards, G-Cloud 6 has enabled Aridhia to offer our services on a monthly subscription basis, opening up the benefits of unlocking insights from healthcare data to all.”
Aridhia has partnered with hosting company Skyscape Cloud Services to deliver the informatics services.
“The G-Cloud programme has made significant progress to date in creating a fairer marketplace for all, boosting opportunities for innovative SMEs and challenging the dominance of inflexible incumbents, while supporting the UK public sector with agile and cost-effective IT solutions,” said Simon Hansford, CEO of Skyscape Cloud Services.
“We welcome the latest iteration and look forward to continuing our partnership with Aridhia on G-Cloud 6 as the framework continues to deliver transformational benefits to the UK public sector.”
Computer scientists at Carnegie Mellon University say neural networks and supervised machine learning techniques can efficiently characterize cells that have been studied using single cell RNA-sequencing (scRNA-seq). This finding could help researchers identify new cell subtypes and differentiate between healthy and diseased cells.